Prion-Like Propagation Mechanisms in Tauopathies and Traumatic Brain Injury: Challenges and Prospects.
Hadeel AlyenbaawiW Ted AllisonSue-Ann MokPublished in: Biomolecules (2020)
The accumulation of tau protein in the form of filamentous aggregates is a hallmark of many neurodegenerative diseases such as Alzheimer's disease (AD) and chronic traumatic encephalopathy (CTE). These dementias share traumatic brain injury (TBI) as a prominent risk factor. Tau aggregates can transfer between cells and tissues in a "prion-like" manner, where they initiate the templated misfolding of normal tau molecules. This enables the spread of tau pathology to distinct parts of the brain. The evidence that tauopathies spread via prion-like mechanisms is considerable, but work detailing the mechanisms of spread has mostly used in vitro platforms that cannot fully reveal the tissue-level vectors or etiology of progression. We review these issues and then briefly use TBI and CTE as a case study to illustrate aspects of tauopathy that warrant further attention in vivo. These include seizures and sleep/wake disturbances, emphasizing the urgent need for improved animal models. Dissecting these mechanisms of tauopathy progression continues to provide fresh inspiration for the design of diagnostic and therapeutic approaches.
Keyphrases
- traumatic brain injury
- cerebrospinal fluid
- severe traumatic brain injury
- spinal cord injury
- induced apoptosis
- risk factors
- white matter
- cell cycle arrest
- early onset
- oxidative stress
- cell death
- resting state
- small molecule
- multiple sclerosis
- sleep quality
- cerebral ischemia
- brain injury
- subarachnoid hemorrhage
- protein protein